Wilterding Mark bought RXST
September 5, 2026 · Form 4 insider transaction
Wilterding Mark bought 258,770 shares of RxSight, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
258,770
Price
N/A
Total value
N/A
InsiderWilterding Mark
RoleOfficer
CompanyRxSight, Inc. (RXST)
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateSeptember 5, 2026
Filing dateSeptember 9, 2026
Shares owned after258,770
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1:1 basis with a post-exchange exercise price of $6.375 per share.; Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter.